1,4-naphthoquinone has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, LK; Jin, CH; Li, JQ; Luo, YH; Piao, XJ; Shen, GN; Wang, H; Wang, JR; Wang, SN; Xu, WT; Xue, H; Zhang, T; Zhang, Y | 1 |
| Feng, YC; Jin, CH; Li, JQ; Luo, YH; Piao, XJ; Shen, GN; Wang, CY; Wang, H; Wang, HX; Wang, JR; Wang, SN; Xu, WT; Xue, H; Zhang, T; Zhang, Y | 1 |
2 other study(ies) available for 1,4-naphthoquinone and Stomach Neoplasms
| Article | Year |
|---|---|
2-(4-methoxyphenylthio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via ROS-mediated MAPK and STAT3 signaling pathway in human gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Mitogen-Activated Protein Kinases; Naphthoquinones; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms | 2019 |
Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Naphthoquinones; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms | 2019 |